
Docbot is an artificial intelligence technology company focusing on gastrointestinal (GI) diseases. Docbot’s products are built on the UltivisionAI software platform for real-time image analysis, automated reporting, and analytic tools to improve patient care and clinical workflows. Docbot's mission is to provide the most powerful AI-assisted image analysis solutions to revolutionize GI care.

Docbot is an artificial intelligence technology company focusing on gastrointestinal (GI) diseases. Docbot’s products are built on the UltivisionAI software platform for real-time image analysis, automated reporting, and analytic tools to improve patient care and clinical workflows. Docbot's mission is to provide the most powerful AI-assisted image analysis solutions to revolutionize GI care.
Focus: AI computer-vision for gastrointestinal endoscopy (real-time polyp detection and workflow automation)
Platform: UltivisionAI — real-time image analysis, automated reporting, and analytics for GI workflows
Status: Acquired by Satisfai Health (announced Nov 21, 2022)
Lead investor: Khosla Ventures (listed as lead for a Series A)
HQ / Founded: Irvine, California; launched June 2014
Company size (db listing): Listed as 1–10 employees (company snapshot shows 4)
Gastrointestinal endoscopy quality and workflow inefficiency (colonoscopy polyp detection, documentation, and billing).
2014
Healthcare AI / Healthtech
Listed by Crunchbase as the last disclosed round (Series A) with Khosla Ventures as lead.
“Backed by notable investors including Khosla Ventures and participation in Y Combinator; Dealroom/Crunchbase list additional investors (e.g., Scale Asia Ventures, Bold Capital Partners) and several investors marked as exited after the acquisition.”